Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

Induction of mesenchymal stem cell‑like transformation in rat primary glial cells using hypoxia, mild hypothermia and growth factors

Wei H., Zhou W., Hu G., Shi C.

Animal Study, published in Mol Med Rep (2021) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Mol Med Rep (2021)
Reported sample size
—
Source database
Europe PMC
PMID
33300053
PMCID
PMC7751450
DOI
10.3892/mmr.2020.11760

Abstract (original English)

The transformation of rat primary glial cells into mesenchymal stem cells (MSCs) is intriguing as more seed cells can be harvested. The present study aimed to evaluate the effects of growth factors, hypoxia and mild hypothermia on the transformation of primary glial cells into MSCs. Rat primary glial cells were induced to differentiate by treatment with hypoxia, mild hypothermia and basic fibroblast growth factor (bFGF) and epidermal growth factor (EGF). Immunohistochemistry and western blotting were then used to determine the expression levels of glial fibrillary acidic protein (GFAP), nestin, musashi‑1, neuron specific enolase (NSE) and neuronal nuclei (NeuN), in each treatment group. bFGF and EGF increased the proportion of CD44 + and CD105 + cells, while anaerobic mild hypothermia increased the proportion of CD90 + cells. The combination of bFGF and EGF, and anaerobic mild hypothermia increased the proportion of CD29 + cells and significantly decreased the proportions of GFAP + cells and NSE + cells. Treatment of primary glial cells with bFGF and EGF increased the expression levels of nestin, Musashi‑1, NSE and NeuN. Anaerobic mild hypothermia increased the expression levels of Musashi‑1 and decreased the expression levels of NSE and NeuN in glial cells. The results of the present study demonstrated that bFGF, EGF and anaerobic mild hypothermia treatments may promote the tr

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
NeurogliaMesenchymal Stem CellsAnimalsRatsRats, Sprague-DawleyHypothermiaEpidermal Growth FactorFibroblast Growth Factor 2Antigens, DifferentiationCell Differentiation

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.